In late April 2023, Helena Gottschling was elected Board Chair for JDRF Canada. Helena Gottschling is a purpose-driven leader who enjoyed a 37-year career with RBC before retiring in 2022. […]
Meet our new Board Chair – Helena Gottschling
JDRF-CIHR Mental Health Grants
Mental health and psychosocial issues remain an under-researched yet frequent aspect of living with type 1 diabetes (T1D). As part of the JDRF-CIHR Partnership to Defeat Diabetes, JDRF is pleased […]
Mental Health and Diabetes – where JDRF is today
May is Mental Health Awareness month, a national movement to raise awareness of the importance of mental health, and the structural gaps that exist in accessing treatment and support. There […]
JDRF International Collaboration Leads to Next-Generation Cell Therapy Research
JDRF Canada and all JDRF affiliates are committed to supporting the development of cell replacement therapies that will one day offer cures for type 1 diabetes (T1D). T1D is an […]
Clinical Trials
In addition to funding critical type 1 diabetes (T1D) clinical trials, a key focus for JDRF is increasing awareness of and participation in trials. All new interventions, from drugs to […]
Why we Walk: The Schaub Family shares their story
Receiving a diagnosis of type 1 diabetes (T1D) for their child can be overwhelming for a family. And it was no different for Tienne and Andreas Schaub, when on April […]
The JDRF-CIHR Partnership to Defeat Diabetes announces 4 new grants in Precision Medicine
Launched in 2017, the JDRF-CIHR Partnership to Defeat Diabetes is a landmark collaboration between the Government of Canada, through the Canadian Institute of Health Research (CIHR) and JDRF Canada for […]
JDRF Canada celebrates International Women’s Day
Wednesday, March 8 is International Women’s Day (IWD), recognized around the world. IWD asks us to imagine a gender equal world. One that is free from bias, stereotypes, and discrimination. […]
Exciting news: new drug in clinical trials shows slowed type 1 diabetes progression in newly diagnosed children and teens
A new JDRF International-funded study of a drug called verapamil is offering exciting new potential for a path to keeping beta cells healthier for longer in people with type 1 […]
Development of a genetic risk score for type 1 diabetes
The causes of type 1 diabetes (T1D) are complex and not fully understood. What is known is that there is a genetic component to developing T1D – but who is […]
Safe and immune cloaked stem cell-derived beta-cells: treatment for type 1 diabetes
A significant part of JDRF Canada’s research strategy is funding the most promising cure-based research for type 1 diabetes (T1D). T1D is an autoimmune disease where the body destroys the […]
JDRF Canada Youth Advocate Tilly Stimpson selected to represent Canada at the JDRF 2023 Children’s Congress
Every two years, more than 160 children living with type 1 diabetes (T1D) gather in Washington, D.C., to meet face-to-face with some of the top decision-makers in the U.S. government. […]
